These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 5918550)

  • 21. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases].
    Hammerl H; Kränzl C; Pichler ; Studlar M
    Munch Med Wochenschr; 1969 Sep; 111(38):1912-6. PubMed ID: 5394857
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E; Rozov H
    Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
    [No Abstract]   [Full Text] [Related]  

  • 25. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

  • 26. Tetranicotinoylfructose in disorders of digital blood flow.
    Holti G; Newell DJ; Poole HG
    Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of acne vulgaris by hexanicit].
    Imura H
    Hifuka Kiyo; 1966 Aug; 61(3):263-5. PubMed ID: 4226974
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of Hexanicotol (inositol niacinate) in peripheral vascular disease.
    Heather AJ
    Del Med J; 1967 Feb; 39(2):33-8. PubMed ID: 5341473
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative thermal imaging to assess inositol nicotinate treatment for Raynaud's syndrome.
    Ring EF; Porto LO; Bacon PA
    J Int Med Res; 1981; 9(6):393-400. PubMed ID: 7319129
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the therapy of cerebral and peripheral circulatory disorders].
    Klein L
    Med Welt; 1969 Aug; 35():1913-6. PubMed ID: 4390197
    [No Abstract]   [Full Text] [Related]  

  • 36. [On prolonged hemokinetic therapy of occlusive arterial diseases].
    Alegría A
    Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983
    [No Abstract]   [Full Text] [Related]  

  • 37. HEMODYNAMIC MECHANISM FOR PULSE CHANGES SEEN IN OCCLUSIVE VASCULAR DISEASE.
    KEITZER WF; FRY WJ; KRAFT RO; DEWEESE MS
    Surgery; 1965 Jan; 57():163-74. PubMed ID: 14244462
    [No Abstract]   [Full Text] [Related]  

  • 38. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
    Chevat H; Steenhouwer B; Hiltenbrand C; Legrand MF; Graux P
    Angeiologie; 1968; 20(2):33-42. PubMed ID: 5682235
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific calcium antagonists in the treatment of peripheral vascular disease.
    Emanuel MB
    Angiology; 1979 Jul; 30(7):454-69. PubMed ID: 464337
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with the treatment of arterial circulatory disorders of the lower extremities using a nicotinic acid preparation].
    Duschek P
    Landarzt; 1968 Oct; 44(30):1480-3. PubMed ID: 5730421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.